Pfizer Asks FDA to Authorize Promising COVID-19 Pill

Published on November 16, 2021

Pfizer said Tuesday it is asking U.S. regulators to authorize its experimental pill for COVID-19, setting the stage for a likely launch of the promising therapy in the coming weeks. The company’s filing comes as new infections are rising once again, driven…

Read Full Article (External Site)